A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future

MLA

Takahisa Ohashi, et al. “A Narrative Review on Drug Development for the Management of Antimicrobial- Resistant Infection Crisis in Japan: The Past, Present, and Future.” Expert Review of Anti-Infective Therapy, vol. 20, Nov. 2022, pp. 1603–14. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bab09390f6415abbfb311f8923e701fa&authtype=sso&custid=ns315887.

APA

Takahisa Ohashi, Masahito Nagashima, Nobuko Kawai, Norio Ohmagari, & Kazuhiro Tateda. (2022). A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future. Expert Review of Anti-Infective Therapy, 20, 1603–1614.

Chicago

Takahisa Ohashi, Masahito Nagashima, Nobuko Kawai, Norio Ohmagari, and Kazuhiro Tateda. 2022. “A Narrative Review on Drug Development for the Management of Antimicrobial- Resistant Infection Crisis in Japan: The Past, Present, and Future.” Expert Review of Anti-Infective Therapy 20 (November): 1603–14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bab09390f6415abbfb311f8923e701fa&authtype=sso&custid=ns315887.